康惠制药(603139) - 2020 Q1 - 季度财报

Financial Performance - Operating revenue for the first quarter was CNY 83,154,948.90, a decline of 4.99% year-on-year[6] - Net profit attributable to shareholders decreased by 32.24% to CNY 6,978,611.77 compared to the same period last year[6] - Basic earnings per share fell by 30% to CNY 0.07[6] - Total operating revenue for Q1 2020 was CNY 83,154,948.90, a decrease of 5.4% compared to CNY 87,523,087.15 in Q1 2019[32] - Net profit attributable to shareholders for Q1 2020 was CNY 7,777,743.72, a decrease from CNY 11,761,166.25 in Q1 2019[32] - The company reported a total profit of CNY 6,659,885.20 for Q1 2020, down 41.3% from CNY 11,306,665.58 in Q1 2019[42] - Net profit for Q1 2020 was CNY 5,725,128.26, down 40.5% from CNY 9,635,681.95 in Q1 2019[42] - Operating profit for Q1 2020 was CNY 7,113,825.20, a decline of 37.8% from CNY 11,321,434.16 in Q1 2019[40] - Total comprehensive income for Q1 2020 was CNY 6,662,258.29, a decrease of 30.5% from CNY 9,635,681.95 in Q1 2019[42] Asset and Liability Changes - Total assets decreased by 3.57% to CNY 1,090,287,845.41 compared to the end of the previous year[6] - The company's total assets decreased from CNY 1.13 billion to CNY 1.09 billion, reflecting a reduction in overall asset value[22] - Total assets as of March 31, 2020, were CNY 1,009,295,049.38, down from CNY 1,043,299,714.28 at the end of 2019[30] - Total liabilities as of March 31, 2020, were CNY 31,875,076.63, a significant decrease from CNY 71,604,869.79 at the end of 2019[30] - Total liabilities amounted to CNY 113,853,555.83, with current liabilities totaling CNY 105,561,947.69[55] Cash Flow Analysis - The net cash flow from operating activities improved by 22.55%, reaching CNY -38,244,737.51[6] - The net cash flow from operating activities improved by 22.55%, from a loss of CNY 49.38 million to a loss of CNY 38.24 million, due to reduced other operating payment expenditures[17] - Cash flow from operating activities for Q1 2020 was negative CNY 38,244,737.51, an improvement from negative CNY 49,376,816.90 in Q1 2019[44] - The net cash flow from investing activities dropped by 97.28%, from CNY 26.90 million to CNY 0.73 million, mainly due to increased payments for project investments[17] - The net cash flow from financing activities increased significantly by 279.28%, from CNY 2.22 million to CNY 8.41 million, attributed to increased bank borrowings[17] - The company reported a net cash flow from financing activities of CNY 8,408,824.22, significantly higher than CNY 2,217,059.92 in Q1 2019[48] Shareholder Information - The total number of shareholders reached 10,024 by the end of the reporting period[10] - The largest shareholder, Shaanxi Kanghui Holdings Co., Ltd., holds 39.65% of the shares and has pledged 27,140,000 shares[10] Operational Changes - The company has not disclosed any significant new product developments or market expansion strategies in this report[13] - The company's trading financial assets decreased by 30.21%, from CNY 192 million to CNY 134 million, due to the recovery of bank wealth management products[14] - Prepayments increased significantly by 139.16%, from CNY 4.26 million to CNY 10.19 million, indicating a rise in advance payments for goods[14] - Other receivables surged by 388.23%, from CNY 7.95 million to CNY 38.82 million, primarily due to increased operational transactions during the reporting period[14] - Construction in progress rose by 62.09%, from CNY 76.65 million to CNY 124.24 million, reflecting payments for fundraising project engineering[14] - Accounts payable decreased dramatically by 87.93%, from CNY 47.78 million to CNY 5.77 million, as the company paid off material costs[14] Research and Development - The company reported a decrease in research and development expenses to CNY 1,562,801.66 from CNY 2,181,261.76, a decline of 28.4%[32] - Research and development expenses for Q1 2020 were CNY 1,562,801.66, down 28.4% from CNY 2,181,261.76 in Q1 2019[40] Other Financial Metrics - The weighted average return on net assets decreased by 0.36 percentage points to 0.71%[6] - Gross profit margin for Q1 2020 was approximately 9.4%, compared to 13.5% in Q1 2019[32] - Cash and cash equivalents decreased to CNY 245,515,791.64 from CNY 280,814,817.30 at the end of 2019, a decline of 12.6%[26] - Inventory levels decreased to CNY 55,266,301.52 from CNY 68,999,557.60, a reduction of 20.0%[26] - Shareholders' equity increased to CNY 977,419,972.75 from CNY 971,694,844.49, reflecting a growth of 0.5%[30]